ARCADIA INVESTMENT MANAGEMENT CORP/MI

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1016972 KALAMAZOO, MI

Position in RXRX

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$1,228

-$408 QoQ

Shares Held

400

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ARCADIA INVESTMENT MANAGEMENT CORP/MI holds $966,746 across 5 Biotechnology names. RXRX ranks #5 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DYN	Dyne Therapeutics, Inc.	49,475	$896,981
2	SRPT	Sarepta Therapeutics, Inc.	2,800	$60,928
3	ARWR	Arrowhead Pharmaceuticals, Inc.	100	$6,270
4	VRTX	Vertex Pharmaceuticals Inc / Ma	3	$1,339
5	RXRX	Recursion Pharmaceuticals, Inc. This page	400	$1,228

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,228	400	0.0%	Shares	Sole	2026-04-22
2025-12-31	$1,636	400	0.0%	Shares	Sole	2026-02-10
2025-09-30	$1,952	400	—	Shares	Sole	2025-10-27
No filing history on record for this holder in this stock.